Translating the promise of 5HT4 receptor agonists for the treatment of depression
Animal experimental studies suggest that 5-HT4 receptor activation holds promise as a novel target for the treatment of depression and cognitive impairment. 5-HT4 receptors are post-synaptic receptors that are located in striatal and limbic areas known to be involved in cognition and mood. Consisten...
Hlavní autoři: | Murphy, SE, de Cates, AN, Gillespie, AL, Godlewska, BR, Scaife, JC, Wright, LC, Cowen, PJ, Harmer, CJ |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Cambridge University Press
2020
|
Podobné jednotky
-
Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial
Autor: de Cates, AN, a další
Vydáno: (2024) -
Déjà-vu? Neural and behavioural effects of the 5-HT4 receptor agonist, prucalopride, in a hippocampal-dependent memory task
Autor: de Cates, AN, a další
Vydáno: (2021) -
5-HT4 receptor agonist effects on functional connectivity in the human brain: implications for procognitive action
Autor: de Cates, AN, a další
Vydáno: (2023) -
The effect of the 5-HT4 agonist, Prucalopride, on a functional magnetic resonance imaging faces task in the healthy human brain
Autor: de Cates, AN, a další
Vydáno: (2022) -
The serotonin 1A (5-HT1A) receptor as a pharmacological target in depression
Autor: Smith, ALW, a další
Vydáno: (2023)